The largest database of trusted experimental protocols

Gsk126

Manufactured by Active Motif
Sourced in United Kingdom, Hong Kong

GSK126 is a potent and selective inhibitor of the EZH2 histone methyltransferase enzyme. It functions by blocking the catalytic activity of EZH2, which is involved in the regulation of gene expression through histone H3 lysine 27 trimethylation (H3K27me3).

Automatically generated - may contain errors

10 protocols using gsk126

1

Neuronal Excitability Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
4’Aminopyridine (4’AP) (50 µM, Sigma-Aldrich, St. Louis, MO, USA-Aldrich) was prepared in an aqueous solution and diphenyl phosphine oxide-1 (DPO-1) (310 nM, Tocris Bioscience, Bristol, UK) and GSK-126 (1 µM, 10 µM, Active Biochem, Maplewood, NJ, USA) were diluted in dimethyl sulfoxide (DMSO). Cells were pre-treated for 72 hours.
+ Open protocol
+ Expand
2

Cell Viability Assay with DAC and GSK-126

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNU398, HepG2 and SNU475 cells were obtained from the American Type Culture Collection (ATCC; www.atcc.org). Each cell line was treated with daily doses of 100 nM DAC (Sigma-Aldrich) and/or 500 nM GSK-126 (Active Biochem, LTD, Hong Kong) for a total of three days. Treated cells continued to grow after the drug(s) were removed. SNU398 and HepG2 cells were harvested on day 14 after treatment, while SNU475 cells were harvested on day 24. Cell survival rates were assessed on specific days using a Coulter counter analyzer (Beckman Coulter, Inc.). Results are normalized to control group (cells treated with phosphate buffered saline (DPBS)). The data are presented as means of triplicate measurements; error bars represent standard errors of the mean (SEMs). The cell doubling times were calculated as described below: Doubling time = A*log(2)/(log(B) − log(C)), in which A is the number of days from cell seeded to harvested, B is the total number of harvested cells, and C is the number of seeded cells.
+ Open protocol
+ Expand
3

Antiviral Effects of GSK126 on VSV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into 24-well plates in DMEM 10% FBS. Once confluent, the cells were infected with VSV∆51-amiR-NTC or VSV∆51-amiR-4 by removing media, adding virus in serum-free media for 1 h, removing inoculum and adding supplemented media. Following 18-h incubation 15 µM GSK126 (Active Biochem) prepared in DMSO or equivalent volume of DMSO was added to the wells. The supernatant was collected for plaque assays, an alamarBlue® Assay was performed and cells were stained with crystal violet at the end of the experiment. A crystal violet cytotoxicity assay was then performed. See Supplementary Fig. 3a for the experimental timeline for different cell lines. For SEV transfer experiments, isolated SEVs derived from mock-infected cells or from MRBΔG-amiR-NTC- and MRBΔG-amiR-4-infected cells were transferred to a confluent monolayer of cells in 48-well plates. The treatment plan including SEV amount transferred can be found in Supplementary Fig. 4g.
+ Open protocol
+ Expand
4

Neuronal Excitability Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
4’Aminopyridine (4’AP) (50 µM, Sigma-Aldrich, St. Louis, MO, USA-Aldrich) was prepared in an aqueous solution and diphenyl phosphine oxide-1 (DPO-1) (310 nM, Tocris Bioscience, Bristol, UK) and GSK-126 (1 µM, 10 µM, Active Biochem, Maplewood, NJ, USA) were diluted in dimethyl sulfoxide (DMSO). Cells were pre-treated for 72 hours.
+ Open protocol
+ Expand
5

Epigenetic Modulation of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNU398, SNU475 and HepG2 cells were purchased form the American Type Culture Collection (ATCC; www.atcc.org), and treated with three daily consecutive doses of SGI-110 (Astex Pharmaceuticals, Dublin, CA) at 100 nM (72 h total exposure) or GSK126 (EZH2 inhibitor, Active Biochem, LTD, Hong Kong) at 500 nM daily. Cells were harvested at the time points indicated in Figure 2A.
+ Open protocol
+ Expand
6

Immunohistochemistry and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
VPA was purchased from Enzo Life Sciences. Stock solutions were prepared in sterile water. Entinostat (MS-275) and vorinostat were from Selleck Chemicals; panobinostat (LBH589) from Novartis International; 5-Azacytidine (azacitidine) was from Sigma; GSK126 was from Active Biochem. Stock solutions were prepared in DMSO. Monoclonal antibodies anti-mouse PD-1 (clone RMP1-14, #BE0146) and anti-mouse CTLA-4 (clone 9H10, #BE0131) were purchased from Bioxcell. Actinomicin D was purchased from Sigma Aldrich.
All media, serum, antibiotics, and glutamine were from Corning.
Primary antibodies (Abs) for western blotting: β-Actin-Ab (Sigma-Aldrich, cod.A5316), Programmed death-ligand 1 (PD-L1)-Ab (Abcam, cod.Ab58810); (PD-L1)-Ab (cod.#13684), acetyl-H3-Ab (cod.#9649), PARP-Ab (cod.#9542) (Cell signaling Technology), and acetyl-H4-Ab (Millipore cod.06946). For IHC: monoclonal anti-mouse Ki67-Ab (Cell signaling Technology; cod.#12202), monoclonal anti-mouse CD4-Ab (Abcam, cod.Ab183685), anti-mouse CD8-Ab (eBioscience, clone 56-6.7). For immunofluorescence on fresh frozen tissues: anti-Foxp3-efluor570 (eBioscience clone FJK-16s, #41-5773-80).
+ Open protocol
+ Expand
7

Epigenetic Screening Protocol and Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small molecules used in the epigenetic screen were obtained from Structural Genomics Consortium or The Wistar Institute Molecular Screening Facility. GSK126 was obtained from Active Biochem or Xcess Biosciences. Antibodies were obtained from: mouse anti-CARM1 (Cell Signaling, Cat. No: 12495, 1:1000 for immunoblotting), goat anti-BAF155 (Santa Cruz, Cat. No: SC9746, 1:1000 for immunoblotting), rabbit anti-methylated R1064 BAF155 (Millipore, Cat. No: ABE1339, 1:1000 for immunoblotting), rabbit anti-EZH2 (Cell Signaling, Cat. No: 5246, 1:1000 for immunoblotting), rabbit anti-cleaved PARP p85 (Promega, Cat. No: G7341, 1:1000 for immunoblotting), mouse anti-Ki67 (Cell Signaling, Cat. No: 9449, 1:500 for IHC), rabbit anti-cleaved caspase 3 (Cell Signaling, Cat. No: 9661, 1:1000 for immunoblotting and 1:50 for IHC), rabbit anti-H3K27Me3 (Cell Signaling, Cat. No: 9733, 1:1000 for immunoblotting and 1:100 for IHC), mouse anti-β-actin (Sigma, Cat. No: A1978, 1:20,000 for immunoblotting), rabbit anti-RNA pol II (Santa Cruz, Cat. No: sc-899). Growth factor reduced basement membrane matrix (Matrigel) was obtained from Corning. Unprocessed scans of blots are available in the Supplementary Fig. 7.
+ Open protocol
+ Expand
8

Ewing Sarcoma Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ewing sarcoma cell lines were cultured in RPMI-1640 media (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (Atlas Biologicals, Inc., Fort Collins, CO, USA) and 6mM L-glutamine (Life Technologies, Grand Island, NY, USA) at 37°C and 5% CO2. For CHLA-25 cells, prior to cell seeding, plates were briefly coated (~5 minutes) with 0.2% Gelatin (Gelatin from bovine skin, Type B). For serum starvation conditions, cells were cultured as above without the presence of FBS for 24 hours. For hypoxia studies, cells were incubated inan xVivo system (Biospherix, Lacona, NY, USA) at 1% O2, 37°C and 5% CO2 for 48 hours. For GSK-126 studies, cells were treated with either vehicle control (DMSO; D128-500, Fisher Scientific, Waltham, MA) or 10μM GSK-126 (A-1275, Active Biochem, Maplewood, NJ) daily for 72 hours prior to functional studies.
+ Open protocol
+ Expand
9

Histone Purification and Western Blotting Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Core histones were purified using a commercial Histone Purification Kit (Active Motif, #40025, Carlsbad, CA, USA) following the manufacturer's instructions, with minor modifications. Briefly, HUVECs were treated with a potent and specific EZH2 inhibitor GSK126 (#A1275, Active Biochem, Hongkong) for the indicated time without changing the media. After washing twice with pre-warmed (37 °C) serum-free M200 media, 0.4 mL ice-cold Extraction Buffer was added to a 60 mm dish. Then, a plastic scraper was used to collect the cell protein extracts. The cells were rotated in Extraction Buffer overnight on a VWR rotating platform at 4 °C to release histones. The following day, cell extracts were transferred to fresh tubes and centrifuged in a microcentrifuge at maximum RCF for 5 min at 4 °C. Crude histones were neutralized with 0.1 mL 5X Neutralization Buffer and purified using columns provided. For Western blots, boiled histone lysates were separated by 12-15% SDS-PAGE. The same membrane was stripped and reprobed with anti-Histone 3 (H3) for equal loading.
+ Open protocol
+ Expand
10

Epigenetic Regulator GSK126 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSK126 was purchased from ActiveBiochem (Kowloon Bay, Kowloon, Hong Kong) and cells were treated with 5 µm for 48 h. MC3629 was synthesized as previously described [38].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!